PanGenetics pangenetics.com


Public lists: Pharma Startups (6570)

PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employs a lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is ...Show all

PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics emplo...Show all

Company (Acquired)

Phone:

Fax:

Yalelaan 46

3584 CM
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PanGenetics $51.6M Nov 12, 2009

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PanGenetics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for the humanization of antibodies and humanized antibodies thereby obtained Dec 23, 2004 Oct 23, 2012 Patent
Gene constructs coding for cd40-binding activating antibodies Apr 08, 2009 Oct 26, 2010 Patent
Cd40-binding activating antibodies Dec 20, 2006 Jun 16, 2009 Patent